Access Biotechnology Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
54
- Portfolio
-
14
- Exits
-
24
Access Biotechnology General Information
Company Description
Founded in 2019, Access Biotechnology is the corporate venture arm of Access Industries, based in New York. The firm seeks to invest in pre-clinical and clinical companies developing therapeutic platforms and products. The firm seeks to invest in the biotech sector.
Business Details
Website
www.accessbio-tech.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 40 West 57th Street
- 28th Floor
- New York, NY 10019
- United States
Access Biotechnology Investments (54)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Velaris Therapeutics | 13-Oct-2026 | PIPE | Drug Discovery | Generating Revenue | ||
| Matchpoint Therapeutics | 07-Oct-2026 | Biotechnology | Generating Revenue | |||
| Talawar Tx | 29-Jun-2026 | Drug Discovery | Generating Revenue | |||
| OnKure Therapeutics | 27-Mar-2026 | Biotechnology | Clinical Trials - Phase 1 | |||
| Vima Therapeutics | 11-Mar-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Recludix Pharma | 12-Jan-2026 | Drug Discovery | Clinical Trials - General | |||
| Hemab Therapeutics Holdings | 27-Oct-2025 | Holding Companies | Generating Revenue | |||
| Draig Therapeutics | 18-Jun-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Surrozen | 26-Mar-2025 | PIPE | Drug Discovery | Generating Revenue/Not Profitable | ||
| Latigo Bio | 17-Mar-2025 | Later Stage VC | Biotechnology | Generating Revenue/Not Profitable |
Access Biotechnology Exits (24)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Latigo Bio | 06-Aug-2026 | IPO | |
| VYNE Therapeutics | 27-Jun-2026 | ||
| Perfuse Therapeutics | 17-Jun-2026 | ||
| Hemab Therapeutics Holdings | 01-May-2026 | ||
| Oruka Therapeutics | 28-Apr-2026 | ||
| Halda Therapeutics | 26-Dec-2025 | ||
| Verona Pharma | 07-Oct-2025 | ||
| Spyre Therapeutics | 19-Nov-2024 | ||
| Upstream Bio | 11-Oct-2024 | IPO | |
| Mariana Oncology | 02-May-2024 | Merger/Acquisition |
Access Biotechnology Investments by Industry, Year, and Region
Access Biotechnology Co-Investors (88)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Atlas Venture | 5 |
|
|
||
| Deep Track Capital |
|
|
|||
| RA Capital Management |
|
|
|||
| Canaan Partners |
|
|
|||
| OrbiMed |
|
|
Access Biotechnology FAQs
-
What is Access Biotechnology?
Founded in 2019, Access Biotechnology is the corporate venture arm of Access Industries, based in New York.
-
When was Access Biotechnology founded?
Access Biotechnology was founded in 2019.
-
Where is Access Biotechnology headquartered?
Access Biotechnology is headquartered in New York, NY.
-
How many investments has Access Biotechnology made?
Access Biotechnology has made 54 investments.
-
What has Access Biotechnology invested in?
Access Biotechnology has made numerous investments in companies like Velaris Therapeutics, Matchpoint Therapeutics, and Talawar Tx within the Drug Discovery and Biotechnology industries.
-
What has Access Biotechnology invested in recently?
Access Biotechnology's latest investment was on 13-Oct-2026 in Velaris Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process